Skip to main content
. 2022 Apr 20;47(4):523–535. doi: 10.1007/s13318-022-00767-8
A population pharmacokinetic model was developed to describe the tacrolimus concentrations in peripheral blood mononuclear cells (PBMCs) using whole-blood concentrations.
Lean body weight and haematocrit values influenced the PBMC:whole blood ratio.
If more information is known about target levels for PBMC tacrolimus, this model can be used to individualize tacrolimus dosing based on predicted intracellular concentrations.